VIGL's Insider Trades

Healthcare

Biotechnology

DATE

INSIDER

COMPANY

OWNED SHARES

SHARES TRADED

PRICE

NET TOTAL

SELL

18 Nov 2022

Papapetropoulos Spyros

Chief Medical Officer, Officer

Vigil Neuroscience, Inc.

(VIGL)

4,000-6%

300

$14.00

$4,200.00

Vigil Neuroscience, Inc.

(VIGL)

1,556,030+2%

36,695

$2.85

$104,410.51

BUY

5 May 2022

Thackaberry Evan

SVP, Head of Early Development, Officer

Vigil Neuroscience, Inc.

(VIGL)

1,500+100%

1,500

$4.00

$6,000.00

BUY

3 May 2022

Papapetropoulos Spyros

Chief Medical Officer, Officer

Vigil Neuroscience, Inc.

(VIGL)

4,000+100%

4,000

$3.40

$13,591.20

BUY

3 May 2022

Ziolkowski Jennifer Lynn

Chief Financial Officer, Officer

Vigil Neuroscience, Inc.

(VIGL)

4,000+100%

4,000

$3.77

$15,097.60

BUY

3 May 2022

Verni Christopher

General Counsel, Officer

Vigil Neuroscience, Inc.

(VIGL)

4,000+100%

4,000

$3.77

$15,074.40

BUY

2 May 2022

Magovcevic-Liebisch Ivana

President and CEO, Director, Officer

Vigil Neuroscience, Inc.

(VIGL)

203,687+2%

5,000

$3.68

$18,379.00

Vigil Neuroscience, Inc.

(VIGL)

3,000+100%

3,000

$7.20

$21,604.20

BUY

11 Jan 2022

Northpond Ventures GP, LLC

10% Owner

Vigil Neuroscience, Inc.

(VIGL)

1,382,978+34%

355,000

$14.00

$4,970,000.00

BUY

11 Jan 2022

Atlas Venture Fund XII, L.P.

10% Owner

Vigil Neuroscience, Inc.

(VIGL)

4,808,896+12%

535,000

$14.00

$7,490,000.00

BUY

11 Jan 2022

Vida Ventures GP III, L.L.C.

10% Owner

Vigil Neuroscience, Inc.

(VIGL)

5,004,393+50%

1,675,000

$14.00

$23,450,000.00

Vigil Neuroscience, Inc.

(VIGL)

4,808,896+12%

535,000

$14.00

$7,490,000.00

Vigil Neuroscience, Inc.

(VIGL)

5,004,393+50%

1,675,000

$14.00

$23,450,000.00

Vigil Neuroscience, Inc.

(VIGL)

1,519,335+21%

265,000

$14.00

$3,710,000.00

Home